HomeInsightsStock Comparison

Brooks Laboratories Ltd vs Emcure Pharmaceuticals Ltd Stock Comparison

Brooks Laboratories Ltd vs Emcure Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 13, 2025

Key Highlights

  • The Latest Trading Price of Brooks Laboratories Ltd is ₹ 153.35 as of 11 Aug 15:30.
  • The P/E Ratio of Brooks Laboratories Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Emcure Pharmaceuticals Ltd changed from 29.8 on March 2025 to 29.8 on March 2025 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Brooks Laboratories Ltd changed from ₹ 153.53 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 20327 crore on March 2025 to ₹ 20327 crore on March 2025 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Brooks Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 23.94 crore. This represent the decline of -100% The revenue of Emcure Pharmaceuticals Ltd for the Jun '25 is ₹ 2104 crore as compare to the Mar '25 revenue of ₹ 2120 crore. This represent the decline of -0.78%.
  • The ebitda of Brooks Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ -0.63 crore. This represent the decline of -100% The ebitda of Emcure Pharmaceuticals Ltd for the Jun '25 is ₹ 416.97 crore as compare to the Mar '25 ebitda of ₹ 396.48 crore. This represent the growth of 5.17%.
  • The net profit of Brooks Laboratories Ltd changed from ₹ -4.47 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 140.97 crore to ₹ 214.79 crore over 9 quarters. This represents a CAGR of 20.58% .
  • The Dividend Payout of Brooks Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Emcure Pharmaceuticals Ltd changed from 25.8 % on March 2020 to 17.92 % on March 2025 . This represents a CAGR of -5.89% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Brooks Laboratories Ltd

  • Brooks Laboratories Limited was incorporated on January 23, 2002.
  • The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis.
  • The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat.
  • Both the units are cGMP compliant in conformity with national and international standards.
  • The Vadodara facility of the company has been approved by European Medicine agency. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc.

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

Brooks Laboratories Ltd News Hub

News

Brooks Laboratories to declare Quarterly Results

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 13 Aug...

Read more

08 Aug 2025 15:17

News

Brooks Laboratories to table results

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 28 May...

Read more

24 May 2025 17:32

News

Brooks Laboratories to declare Quarterly Results

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 13 Feb...

Read more

11 Feb 2025 13:40

News

Brooks Laboratories EGM scheduled

Brooks Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company ...

Read more

21 Dec 2024 09:53

News

Brooks Laboratories to conduct board meeting

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 11 Dec...

Read more

09 Dec 2024 09:31

News

Brooks Laboratories schedules board meeting

Brooks Laboratories will hold a meeting of the Board of Directors of the Company on 9 Nove...

Read more

08 Nov 2024 20:35

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals to hold AGM

Emcure Pharmaceuticals announced that the 44th Annual General Meeting(AGM) of the company ...

Read more

02 Aug 2025 14:15

News

Emcure Pharmaceuticals to discuss results

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 A...

Read more

29 Jul 2025 10:54

News

Emcure Pharmaceuticals signs exclusive agreement with Sanofi India

Emcure Pharmaceuticals (Emcure) and Sanofi India (SIL) today entered into an exclusive dis...

Read more

16 Jul 2025 17:38

News

Emcure Pharmaceuticals appoints President ' India Business

Emcure Pharmaceuticals has appointed R.S. Vasan as President ' India Business and Senior M...

Read more

14 Jul 2025 13:17

News

Emcure Pharma gains after Sanand facility gets zero observations from USFDA

The inspection conducted from 30 June 2025 to 08 July 2025 and concluded without issuance ...

Read more

10 Jul 2025 09:50

News

Board of Emcure Pharmaceuticals recommends final dividend

Emcure Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:02

SWOT Analysis Of Brooks Laboratories Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Brooks Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Brooks Laboratories Ltd and Emcure Pharmaceuticals Ltd

Which company has a larger market capitalization, Brooks Laboratories Ltd or Emcure Pharmaceuticals Ltd?

Market cap of Brooks Laboratories Ltd is 438 Cr while Market cap of Emcure Pharmaceuticals Ltd is 26,697 Cr

What are the key factors driving the stock performance of Brooks Laboratories Ltd and Emcure Pharmaceuticals Ltd?

The stock performance of Brooks Laboratories Ltd and Emcure Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Brooks Laboratories Ltd and Emcure Pharmaceuticals Ltd?

As of August 13, 2025, the Brooks Laboratories Ltd stock price is INR ₹148.78. On the other hand, Emcure Pharmaceuticals Ltd stock price is INR ₹1408.8.

How do dividend payouts of Brooks Laboratories Ltd and Emcure Pharmaceuticals Ltd compare?

To compare the dividend payouts of Brooks Laboratories Ltd and Emcure Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions